[The results of treatment of XXXX in the Provincial Hospital in Zielona G  ra].

@entity1 @entity0 @entity5 @entity204 @entity420 @entity356
INTRODUCTION: @entity356 is the third leading cause of @entity204 from @entity5 worldwide in both sexes, following lung and @entity0 . The incidence of @entity356 in Poland is approximately 5% in @entity1 and approximately 2.5% in @entity1 , among the complete incidence of @entity5 . Deaths from @entity356 in @entity1 in Poland in 2009 amounted to 6.6%, while in @entity1 --4.6%. The highest mortality rate in @entity1 is observed in the Lubuskie, Podkarpackie, Slaskie and Opolskie provinces. European average 5-year survival in the EUROCARE-4 study is 24.5%. AIM: The aim of this paper was to assess the treatment of @entity356 in the Department of General and Oncological Surgery of the Provincial Hospital in Zielona G  ra. MATERIALS AND METHODS: The retrospective analysis of 109 @entity1 with @entity356 , operated in the years 2003-2007, was performed. The analysis included @entity1 scheduled for admission with the histopathological confirmation of @entity420 , prepared to and subjected to laparotomy. The post-operative intrahospital deaths were estimated up to 30 days after surgery. The analysis of the survival rates was performed up to 1, 6, 12, 36 and 60 months since lapatoromy. All the continuous variables with the standard distribution were expressed as the mean    standard deviation, while the total survival rates were assessed by means of the Kaplan-Meier method. RESULTS: 55 @entity1 (50.5%) underwent the radical surgical procedure intended to cure them. The remaining 54 @entity1 (49.5%) could not be qualified for the radical surgical procedures. In 35 cases (32%) underwent laparotomy with biopsy, in 19 cases (17%) palliative surgery (intestinal bypass, gastrostomy, palliative resection). Out of 55 @entity1 underwent the radical surgical procedure 9 @entity1 died after the procedure (16.4%). The survival rates calculated for all the @entity1 revealed that 21.1% @entity1 survived 5 years after the surgery. CONCLUSIONS: Almost a half of the @entity1 (49.5%) who were admitted for treatment had an advanced stage of the disease that could not be qualified for the radical surgical procedures. The distant results of surgical treatment are non-satisfactory due to the fact that the disease was so advanced. 5-year-long survival rates (21.1% in our data) are higher that the ones listed in the EUROCARE-4 test for Poland (14.4%), but lower than the European average (24.5%).
